Showing results (1-10 of 297) with videos related to
Sort By:
Pageof 30
Therapeutic Drug Monitoring|January 1, 1981
Effect of antacids on phenytoin bioavailabilityB L Carter, W R Garnett, J M Pellock, et al.Therapeutic Drug Monitoring|November 1, 1989
Usefulness of a single-dose prediction model for the determination of long-term maintenance therapy of valproic acidC B Pugh, W R Garnett, J M PellockTherapeutic Drug Monitoring|January 1, 1987
A comparative bioavailability study of carbamazepine tablets and a chewable tablet formulationB Maas, W R Garnett, J M Pellock, et al.American Journal of Hospital Pharmacy|October 1, 1981
Effects of food on valproic acid absorptionR A Hamilton, W R Garnett, B J Kline, et al.Therapeutic Drug Monitoring|January 1, 1986
Influence of tube type, storage time, and temperature on the total and free concentration of valproic acidC G Tarasidis, W R Garnett, B J Kline, et al.Clinical Pharmacy|May 1, 1982
Effects of three antacids on the bioavailability of valproic acidC A May, W R Garnett, R E Small, et al.Clinical Pharmacy|November 1, 1984
Single-dose model for predicting steady-state valproic acid serum concentrations in seizure patientsC B Pugh, W R Garnett, W J Poynor, et al.Epilepsia|July 1, 1986
Single dose comparison of the relative bioavailability of phenytoin suspension and extended capsulesW E Fitzsimmons, W R Garnett, T J Comstock, et al.Journal of the American Geriatrics Society|June 1, 1981
Monitoring digoxin therapy in two long-term facilitiesB L Carter, R E Small, W R GarnettEpilepsia|November 1, 1987
Effect of two administration schedules of an enteral nutrient formula on phenytoin bioavailabilityK A Krueger, W R Garnett, T J Comstock, et al.Pageof 30